About

EDITOR'S EMULSION 1st Apr 2018

EDITOR'S EMULSION 1st Apr 2018


Greetings on yet another edition of The Prescription!

 

Fake medicines has always been an issue of grave concern for all. The manufacturers of these life threatening pills go to any extent to contaminate the market with their illegal products, costing heavy on the lives of many. PSM India capsule captures the details on this menace.

 

On one hand, while the AP government plans to implement the Comprehensive Drug Monitoring System to facilitate better inventory and supply chain management by manufacturers /wholesalers/ retailers/doctors to keep a tab on the medicine being supplied in the State; Tamil Nadu government, on the other hand decides to make registration for hospitals, clinics mandatory. This will ensure basic standards and also help the state crackdown on quackery. Read more on this and other news such as drug labelling notification rule, health ministry finalising the draft bill to establish national electronic health authority, regulatory body formed for medical devices under Drug Laws and Policy Injections.

 

Drug Dopes gives you an insight into the list of new approved drugs, drug withdrawals from the market, smuggled drugs consignment seizure and various spurious drug rackets getting unearthed.

 

While this issue of National Injections deals with a special focus on TB, the rise in TB cases in Mumbai and the health ministry launching new initiatives to combat it, with a thousand rupees incentive being offered to every informer of intimating the Govt on a TB patient; our Pharma Injections covers news on firms coming under the scanner for selling drugs without safety trials and firms under CDSCO lens over unapproved drugs; anti dumping duty being imposed on imports from China and Pharmaceutical companies no longer having to obtain a drug regulatory clearance for exporting drugs and medical devices.

 

We constantly endeavour not only to reach you important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to feature them under the section titled Subscriber’s Symptoms. This issue touches on how one can avoid Endocrine Disruptors.

 

 

Also, from our last 2 editions of The Prescription, we have started an informative series of FAQs on Universal Health Coverage. Find part 3 on the same in this issue while part 1 and 2 are available on our website www.safemedicinesindia.in under the archive section of our newsletters dated 1st March and 17th March respectively.

 

 

Do not hesitate to mail your comments on this newsletter to help us improve further. We appreciate your support and trust in us and are happy to have you as our loyal reader.

Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@safemedicinesindia.in

 

Stay Healthy. Stay Protected.

 

Pooja Khaitan

Editor-in-Chief,

The Prescription